TUNICRIS-julkaisut - Trepo

Viitteet 1-1 / 1

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy

Schober, Sebastian Johannes; Hallmen, Erika; Reßle, Florian; Gassmann, Hendrik; Prexler, Carolin; Wawer, Angela; von Luettichau, Irene; Ladenstein, Ruth; Kazanowska, Bernarda; Ljungman, Gustaf; Niggli, Felix; Lohi, Olli; Hauer, Julia; Gruhn, Bernd; Klingebiel, Thomas; Bader, Peter; Burdach, Stefan; Lang, Peter; Sparber-Sauer, Monika; Koscielniak, Ewa; Thiel, Uwe (10.05.2022)
article

Background: Patients with stage IV alveolar rhabdomyosarcoma (RMA) have a 5-year-survival rate not exceeding 30%. Here, we assess the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for these patients ...